Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

So-Young International Inc (SY)

  • Technical Exchange News
  • Sept. 05, 2024, 18:50 UTC
  • 48
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Cadrenal Therapeutics Inc (CVKD)

  • Technical Exchange News
  • Sept. 05, 2024, 18:49 UTC
  • 50
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

RedHill Biopharma (RDHL)

  • Technical Exchange News
  • Sept. 05, 2024, 01:53 UTC
  • 56
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Lifecore Biomedical (LFCR)

  • Technical Exchange News
  • Sept. 05, 2024, 01:53 UTC
  • 52
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text

Biodexa Pharmaceuticals PLC (BDRX)

  • Technical Exchange News
  • Sept. 05, 2024, 01:53 UTC
  • 53
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

RedHill Biopharma (RDHL)

  • Technical Exchange News
  • Sept. 04, 2024, 19:27 UTC
  • 50
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Lifecore Biomedical (LFCR)

  • Technical Exchange News
  • Sept. 04, 2024, 19:27 UTC
  • 55
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text

Biodexa Pharmaceuticals PLC (BDRX)

  • Technical Exchange News
  • Sept. 04, 2024, 19:26 UTC
  • 54
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Avalo Therapeutics Inc. (AVTX)

  • Technical Exchange News
  • Sept. 04, 2024, 01:46 UTC
  • 63
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aligos Therapeutics (ALGS)

  • Technical Exchange News
  • Sept. 04, 2024, 01:46 UTC
  • 57
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 758
  • 759
  • 760
  • 761
  • 762
  • Next

Search

News categories

  • Technical Exchange News(14434)
  • Event(6229)
  • SEC News(378788)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(231130)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin